Glerelin is a prescription medication used to treat certain types of prostate cancer, including advanced prostate cancer.
Composition:
Each 1.4mL injection of Glerelin contains 22.5mg of leuprolide acetate.
Mechanism of Action:
Leuprolide works by:
- Suppressing the production of testosterone in the body, which can help slow or stop the growth of prostate cancer cells
- Reducing the levels of testosterone in the blood, which can help slow or stop the growth of prostate cancer cells
Uses:
Glerelin is used to treat:
- Advanced prostate cancer (cancer that has spread to other parts of the body)
- Prostate cancer that has not responded to other treatments
- Prostate cancer that has recurred after other treatments
Dosage:
The recommended dosage of Glerelin is:
- 22.5mg injected every 3 months (every 90 days)
Side Effects:
Common side effects of Glerelin include:
- Hot flashes
- Nausea and vomiting
- Headache
- Fatigue
- Muscle pain
- Increased risk of urinary retention
- Increased risk of bone fractures
Recommendation:
Glerelin is recommended for patients with advanced prostate cancer who have not responded to other treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.
Important Note:
Patients should not take Glerelin if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking Glerelin.
Some common brands of leuprolide include:
- Lupron (TAP Pharmaceuticals)
- Eligard (Sanofi-aventis)
Please note that Glerelin is not available in all markets and may be approved for different indications and dosages in different regions.
Reviews
There are no reviews yet.